Press releases
- FDA approves GSK’s BLENREP (belantamab mafodotin-blmf) for the treatment of patients with relapsed or refractory multiple myeloma
- GSK launches national public awareness campaign to reverse steep decline in already low immunization rates for adults
- Sanofi and GSK selected for Operation Warp Speed to supply United States Government with 100 million doses of COVID-19 vaccine
Tweets from GSK US
-
GSKUS @GSKUS
While #ATS2020 may look different this year, respiratory expert, Dr. Nestor Molfino, reminds us that both our pursuit of new #research and our commitment to patients remains the same. Check out what we are doing this year: 👉gsk.to/3gLVwckg#ScienceOnTheSofaa
about 2 days ago
g
-
GSKUS @GSKUS
In one hour, an expert #ATS2020 panel will convene to discuss approaches to identifying and managing people living with severe eosinophilic #asthma (SEA). Visit the ATS virtual program for more information. 👉gsk.to/33AHh6C0
about 3 days ago
K
-
GSKUS @GSKUS
With this year’s #ATS2020 going virtual, Edwin, our Director of HCP Engagement is looking forward to connecting with a larger group of #respiratory HCPs. Join us for #ScienceOnTheSofa all week. 👉gsk.to/3fAl8HRT
about 3 days ago
W
